Skip to content

Evaluation of curative effect of integrated Traditional Chinese and Western medicine on children's community acquired pneumonia

Evaluation of curative effect of integrated Traditional Chinese and Western medicine on children's community acquired pneumonia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005642
Enrollment
Unknown
Registered
2022-02-17
Start date
2020-11-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia in children

Interventions

Integrated Traditional Chinese and Western medicine treatment group:Oral administration of Chinese medicine + external treatment of Chinese medicine
Western medicine Treatment Group:Oral Chinese medicine placebo + external Chinese medicine placebo + Western medicine treatment
CWPW

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Those who meet the diagnostic criteria of community-acquired pneumonia for children in western medicine; 2.Age =12 months, =14 years old; 3.The legal guardian understands and signs the informed consent(Children over 8 years of age who understand and can sign their names also need to sign).

Exclusion criteria

Exclusion criteria: 1.Patients with other respiratory diseases except children with community-acquired pneumonia; 2.Patients with severe primary diseases such as heart (congenital heart disease, myocarditis, etc.), liver (AST, ALT= 1.5 times the upper limit of normal value), kidney (BUN > 8.2mmol/L, Scr > 104 mol/L, etc.) and hematopoietic system (anemia of moderate or above); 3.Those who are allergic to experimental drugs; 4.Patients who have participated in or are participating in clinical trials of other drugs within the last three months; 5.The researchers did not consider the subjects suitable for inclusion in the clinical trial.

Design outcomes

Primary

MeasureTime frame
The total effective rate of disease;

Secondary

MeasureTime frame
Cure rate;Length of stay;Total antifebrile time;Clinical recovery time;Efficacy of single symptom;Curative effect of TCM syndromes;Total cost;

Countries

China

Contacts

Public ContactZhang Baoqing
baoqing09009@126.com13793188117

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026